BamSEC and AlphaSense Join Forces
Learn More

Seelos Therapeutics Inc. – Underwriting Agreements

Formerly OTC: SEELQ
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from 8-K 46 pages Underwriting Agreement Between Seelos Therapeutics, Inc. and Titan Partners Group LLC, a Division of American Capital Partners, LLC as Representative of the Several Underwriters Seelos Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 40 pages Open Market Sale Agreementsm
12/34/56
EX-1.1
from 8-K 57 pages 19,354,840 Shares of Common Stock Seelos Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 37 pages 15,243,903 Shares Seelos Therapeutics, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 42 pages 7,500,000 Shares of Common Stock of Seelos Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 42 pages 6,666,667 Shares of Common Stock of Seelos Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 42 pages Shares of Common Stock of Seelos Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 43 pages Seelos Therapeutics, Inc. Equity Distribution Agreement
12/34/56
EX-1
from SC 13G 1 page Joint Filing Agreement Pursuant to Rule 13d-1
12/34/56
EX-1.1
from S-1/A 38 pages Shares of Common Stock and Warrants of Apricus Biosciences, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 45 pages Shares of Common Stock and Warrants of Apricus Biosciences, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 50 pages 6,000,000 Shares of Common Stock, Par Value $0.001 Warrants to Purchase 3,000,000 Shares of Common Stock and 900,000 Over-Allotment Shares Over-Allotment Warrants to Purchase 450,000 Shares of Common Stock Apricus Biosciences, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 10-Q 2 pages Apricus Biosciences, Inc. Controlled Equity Offering Amendment No. 1 to Controlled Equity Offering Agreement
12/34/56
EX-1.1
from 8-K 48 pages 4,938,272 Shares of Common Stock, Par Value $0.001 Warrants to Purchase 2,469,136 Shares of Common Stock and 740,740 Over-Allotment Shares Over-Allotment Warrants to Purchase 370,370 Shares of Common Stock Apricus Biosciences, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 28 pages Controlled Equity Offering Agreement December 30, 2011
12/34/56
EX-1.1
from 8-K 23 pages Nexmed, Inc. Docs® Financing Facility $10,000,000 of Common Stock, $0.001 Par Value Sales Agreement April 21, 2010
12/34/56
EX-1
from SC 13G/A 2 pages Joint Filing Agreement [Signature Page Follows]
12/34/56